SCHEMBL3758559

SCHEMBL3758559

CCCCCCCCCCCC(O)C(O)CCCCC(=O)O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.78
FFAR1 O14842 2/20 0.78
GPR84 Q9NQS5 7/20 0.71
PPARG P37231 7/20 0.71
PPARD Q03181 7/20 0.71
PPARA Q07869 7/20 0.71
HDAC11 Q96DB2 5/20 0.71
TSHR P16473 4/20 0.71
PTPN1 P18031 3/20 0.71
ALDH1A1 P00352 2/20 0.71
TLR2 O60603 2/20 0.71
TDP1 Q9NUW8 2/20 0.71
FABP4 P15090 2/20 0.71
KMT2A Q03164 2/20 0.71
SLC22A6 Q4U2R8 1/20 0.71
SLC22A8 Q8TCC7 1/20 0.71
MEN1 O00255 1/20 0.71
ESR1 P03372 1/20 0.71
ALOX15 P16050 1/20 0.71
PDE4A P27815 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6300670 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL8539791 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL10947946 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL17911294 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL1275084 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL10952918 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL4402579 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL1274520 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL8633366 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL316901 1.00 FFAR4 (0.78) FFAR4FFAR1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426625-B2 Bis-platinum complexes with antitumor activity CELL THERAPEUTICS, INC. (US) 2013-04-23 US claimed
US-20100292322-A1 Bis-Platinum Complexes With Antitumor Activity CELL THERAPEUTICS, INC. 2010-11-18 US claimed
EP-1968991-A1 BIS-PLATINUM COMPLEXES WITH ANTITUMOR ACTIVITY Sede Secondaria Della Cell Therapeutics, Inc. (IT) 2008-09-17 EP claimed
WO-2007071415-A1 BIS-PLATINUM COMPLEXES WITH ANTITUMOR ACTIVITY CELL THERAPEUTICS, INC. - SEDE SECONDARIA (IT) 2007-06-28 WO claimed
US-20180072937-A1 ADDITIVE COMPOSITIONS FOR DRILLING FLUIDS AND METHODS FOR THEIR USE THE LUBRIZOL CORPORATION 2018-03-15 US disclosed
CN-107750268-A Additive composition for drilling fluids and methods of use thereof 路博润公司 2018-03-02 CN disclosed
EP-3283596-A1 ADDITIVE COMPOSITIONS FOR DRILLING FLUIDS AND METHODS FOR THEIR USE The Lubrizol Corporation (US) 2018-02-21 EP disclosed
WO-2016168177-A1 ADDITIVE COMPOSITIONS FOR DRILLING FLUIDS AND METHODS FOR THEIR USE THE LUBRIZOL CORPORATION (US) 2016-10-20 WO disclosed
WO-2016019216-A1 ADDITIVE COMPOSITION FOR WELL TREATMENT FLUIDS AND METHODS FOR THEIR USE THE LUBRIZOL CORPORATION (US) 2016-02-04 WO disclosed
US-8426625-B2 Bis-platinum complexes with antitumor activity CELL THERAPEUTICS, INC. (US) 2013-04-23 US disclosed
US-20100292322-A1 Bis-Platinum Complexes With Antitumor Activity CELL THERAPEUTICS, INC. 2010-11-18 US disclosed
EP-0802254-B1 Refrigerator oil composition IDEMITSU KOSAN CO (JP) 2003-07-09 EP disclosed
US-6008169-A Refrigerator oil composition comprising saturated hydroxy fatty acids and derivatives thereof IDEMITSU KOSAN CO., LTD. (JP) 1999-12-28 US disclosed
EP-0802254-A1 Refrigerator oil composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1997-10-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292322-A1 Bis-Platinum Complexes With Antitumor Activity IDH3B, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, IDH1 FFAR4 3876/4885FFAR1 3380/4885GPR84 4253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.